Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 38,000 trials and 12 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and one of the largest clinical trial data sets in the industry. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC.
Statista aims to empower people worldwide to make better and faster fact-based business decisions by providing a simple-to-use and affordable global business-data platform.
Our innovative spirit is strengthened by an international and diverse team of over 1,100 employees representing more than 70 nations working at 8 office locations around the globe including our HQ in Hamburg, New York City, London, Singapore, Tokyo, Gurugram, and Berlin.
ObvioHealth is an enterprise SaaS provider transforming how clinical trials are designed, delivered, and managed. Our end-to-end ObvioGo® platform unifies study design, operational oversight, patient engagement, logistics, safety monitoring, and real-time data capture in one secure, scalable digital ecosystem.
Designed for biotech, pharma, and CRO teams, ObvioGo® enables decentralized, hybrid, and site-enabled studies through three seamlessly integrated modules: Study Designer, Study Manager, and the ObvioGo App. Together, they streamline protocol configuration, automate study workflows, and make it easier for participants to contribute data from anywhere.
The platform supports high-quality evidence generation with features including ePRO/eCOA capture, remote assessments, device and wearable integrations, real-time compliance monitoring, adverse event alerts, supply management, and automated audit trails. This unified approach reduces operational burden, accelerates timelines, and strengthens data accuracy.
By bringing every component of the clinical trial into a single platform, ObvioHealth gives sponsors and CROs the software they need to run smarter, more efficient studies—while providing a patient experience designed for everyday life.
Visit ObvioHealth.com to learn how our SaaS platform is modernizing digital and decentralized clinical research.